Active vitamin D analog and SARS‐CoV‐2 IgG after BNT162b2 vaccination in patients with hemodialysis

Introduction Vaccination is the effective strategy for coronavirus disease 2019 (COVID‐19). However, few studies have investigated the association between severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) immunoglobulin (Ig)G and vitamin D. Methods This study aimed to investigate the asso...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2024-08, Vol.28 (4), p.599-607
Main Authors: Nakashima, Akio, Yamamoto, Izumi, Kobayashi, Arisa, Kimura, Keita, Yaginuma, Tatsuhiro, Nishio, Shinichiro, Kato, Kazuhiko, Kawai, Rena, Horino, Tetsuya, Ohkido, Ichiro, Yokoo, Takashi
Format: Article
Language:English
Subjects:
active vitamin D analog SARS‐CoV‐2 IgG
hemodialysis
vaccine
vitamin D
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Vaccination is the effective strategy for coronavirus disease 2019 (COVID‐19). However, few studies have investigated the association between severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) immunoglobulin (Ig)G and vitamin D. Methods This study aimed to investigate the association between SARS‐CoV‐2 IgG and active vitamin D analogs in hemodialysis patients. Blood samples were collected four times: before vaccination and 30, 60, and 90 days after vaccination, BNT162b2 (Pfizer©). Results A total of 418 patients were enrolled. The mean age was 71.1 ± 12 years. Almost two thirds of the patients were prescribed active vitamin D analogs. The distribution of SARS‐CoV‐2 IgG before vaccination was 235 (93–454) AU/mL. After multiple regression analyses, active vitamin D analog use was found to be associated with higher SARS‐CoV‐2 IgG levels from prevaccination to 90 days postvaccination. Conclusion This study demonstrated an association between higher SARS‐CoV‐2 IgG and active vitamin D analog use in hemodialysis patients. Clinical trial registration: The study information was registered in the UMIN‐CTR (UMIN 000046906).
ISSN:1744-9979
1744-9987
1744-9987
DOI:10.1111/1744-9987.14121